Cubist Systematic Strategies LLC Boosts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

Cubist Systematic Strategies LLC boosted its position in Definitive Healthcare Corp. (NASDAQ:DH) by 213.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 219,481 shares of the company’s stock after purchasing an additional 149,533 shares during the quarter. Cubist Systematic Strategies LLC owned approximately 0.19% of Definitive Healthcare worth $1,198,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Swiss National Bank boosted its position in shares of Definitive Healthcare by 2.9% in the 1st quarter. Swiss National Bank now owns 103,300 shares of the company’s stock worth $834,000 after purchasing an additional 2,900 shares in the last quarter. Principal Financial Group Inc. grew its stake in shares of Definitive Healthcare by 10.8% during the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock worth $218,000 after acquiring an additional 3,874 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after acquiring an additional 5,083 shares in the last quarter. Valeo Financial Advisors LLC raised its position in shares of Definitive Healthcare by 11.8% in the 2nd quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company’s stock valued at $323,000 after purchasing an additional 6,230 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Definitive Healthcare by 1.9% in the 2nd quarter. Victory Capital Management Inc. now owns 509,009 shares of the company’s stock worth $2,779,000 after purchasing an additional 9,316 shares in the last quarter. 98.67% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DH. Robert W. Baird cut their price target on shares of Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Tuesday, August 6th. JPMorgan Chase & Co. cut Definitive Healthcare from a “neutral” rating to an “underweight” rating and lowered their price target for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. Barclays cut their price objective on Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating for the company in a report on Friday, August 9th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $5.81.

Definitive Healthcare Price Performance

Shares of NASDAQ DH opened at $4.34 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The stock has a market capitalization of $511.84 million, a price-to-earnings ratio of -2.51, a PEG ratio of 6.49 and a beta of 1.33. The firm’s 50 day simple moving average is $4.42 and its 200-day simple moving average is $5.65. Definitive Healthcare Corp. has a 12 month low of $3.19 and a 12 month high of $10.62.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings data on Monday, August 5th. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. Definitive Healthcare had a negative net margin of 156.65% and a positive return on equity of 0.98%. The company had revenue of $63.70 million during the quarter, compared to analysts’ expectations of $63.19 million. During the same quarter in the previous year, the company earned $0.08 earnings per share. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. Analysts expect that Definitive Healthcare Corp. will post 0.07 EPS for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.